ALLOGENE THERAPEUTICS INC shareholders Q2 2024

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

ALLOGENE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
LPL Financial LLC 125,575$292,5900.00%
ENVESTNET ASSET MANAGEMENT INC 13,961$32,5290.00%
AdvisorNet Financial, Inc 200$4660.00%
MACQUARIE GROUP LTD 146,779$342,0000.00%
Citadel Advisors 13,700$31,9210.00%
Citadel Advisors 42,400$98,7920.00%
Covestor Ltd 19$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 80,600$187,7980.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 69,200$161,2360.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 87,742$204,4390.00%
Parkside Financial Bank & Trust 159$3710.00%
Dunhill Financial, LLC 70$1630.00%
SIGNATUREFD, LLC 601$1,4000.00%
HighTower Advisors, LLC 30,556$72,0000.00%
Daiwa Securities Group Inc. 26,360$610.00%
External links

This page lists ALLOGENE THERAPEUTICS INC's shareholders in Q2 2024. To view ALLOGENE THERAPEUTICS INC's shareholder history, click here.